BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34139209)

  • 1. Local complement factor H protects kidney endothelial cell structure and function.
    Mahajan S; Jacob A; Kelkar A; Chang A; Mcskimming D; Neelamegham S; Quigg RJ; Alexander JJ
    Kidney Int; 2021 Oct; 100(4):824-836. PubMed ID: 34139209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
    Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
    J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement factor H: a guardian within?
    Boudhabhay I; Roumenina LT
    Kidney Int; 2021 Oct; 100(4):747-749. PubMed ID: 34556298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
    Lesher AM; Zhou L; Kimura Y; Sato S; Gullipalli D; Herbert AP; Barlow PN; Eberhardt HU; Skerka C; Zipfel PF; Hamano T; Miwa T; Tung KS; Song WC
    J Am Soc Nephrol; 2013 Jan; 24(1):53-65. PubMed ID: 23204401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
    Ruseva MM; Takahashi M; Fujita T; Pickering MC
    Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the physiology, exploration and disease relevance of complement factor H.
    Buhé V; Loisel S; Pers JO; Le Ster K; Berthou C; Youinou P
    Int J Immunopathol Pharmacol; 2010; 23(2):397-404. PubMed ID: 20646335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells.
    Cabezas S; Bracho G; Aloia AL; Adamson PJ; Bonder CS; Smith JR; Gordon DL; Carr JM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
    Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
    Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
    J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homodimeric Minimal Factor H:
    Kamala O; Malik TH; Hallam TM; Cox TE; Yang Y; Vyas F; Luli S; Connelly C; Gibson B; Smith-Jackson K; Denton H; Pappworth IY; Huang L; Kavanagh D; Pickering MC; Marchbank KJ
    Front Immunol; 2021; 12():752916. PubMed ID: 34956184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus and the complement alternative pathway.
    Carr JM; Cabezas-Falcon S; Dubowsky JG; Hulme-Jones J; Gordon DL
    FEBS Lett; 2020 Aug; 594(16):2543-2555. PubMed ID: 31943152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
    Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.
    Merle NS; Leon J; Poillerat V; Grunenwald A; Boudhabhay I; Knockaert S; Robe-Rybkine T; Torset C; Pickering MC; Chauvet S; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2020; 11():1772. PubMed ID: 32849636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ.
    Dixon KO; O'Flynn J; Klar-Mohamad N; Daha MR; van Kooten C
    Eur J Immunol; 2017 Mar; 47(3):470-480. PubMed ID: 28105653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
    Ruseva MM; Peng T; Lasaro MA; Bouchard K; Liu-Chen S; Sun F; Yu ZX; Marozsan A; Wang Y; Pickering MC
    J Am Soc Nephrol; 2016 Feb; 27(2):405-16. PubMed ID: 26047789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice.
    Casiraghi F; Ordonez PYR; Azzollini N; Todeschini M; Rottoli D; Donadelli R; Gramignoli R; Benigni A; Noris M; Remuzzi G
    Stem Cell Res Ther; 2021 Jun; 12(1):332. PubMed ID: 34112227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade.
    Daugan MV; Revel M; Thouenon R; Dragon-Durey MA; Robe-Rybkine T; Torset C; Merle NS; Noé R; Verkarre V; Oudard SM; Mejean A; Validire P; Cathelineau X; Sanchez-Salas R; Pickering MC; Cremer I; Mansuet-Lupo A; Alifano M; Sautès-Fridman C; Damotte D; Fridman WH; Roumenina LT
    Cancer Immunol Res; 2021 Aug; 9(8):909-925. PubMed ID: 34039652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.